Molecular epidemiology of extended-spectrum -lactamase-, AmpC -lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11
Author(s) -
Andrew Denisuik,
Philippe LagacéWiens,
Johann Pitout,
M. R. Mulvey,
P. J. Simner,
Franil Tailor,
James A. Karlowsky,
D. J. Hoban,
Heather J. Adam,
George G. Zhanel,
Melanie Baxter,
Kimberly A. Nichol,
Andrew Walkty
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt027
Subject(s) - klebsiella pneumoniae , microbiology and biotechnology , escherichia coli , enterobacteriaceae , klebsiella , biology , antibiotics , beta lactamase , molecular epidemiology , antibiotic resistance , genotype , gene , genetics
To assess the proportion of Escherichia coli and Klebsiella pneumoniae from Canadian hospitals that produce extended-spectrum β-lactamases (ESBLs), AmpC β-lactamases and carbapenemases, as well as to describe the patterns of antibiotic resistance and molecular characteristics of these organisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom